Ascendis Pharma Total Liabilities Fall to EUR 926.73 Million From EUR 1.47 Billion
Bitget2026/11/12 12:54- Ascendis Pharma assets rose to EUR 2.43 billion at September 30, 2026, from EUR 1.3 billion at December 31, 2025.
- Total liabilities fell to EUR 926.73 million from EUR 1.47 billion over the same period.
- May's conversion of 2.25% convertible notes due 2028 transferred EUR 719.4 million of liabilities to equity, with no profit impact.
- Deferred tax assets reached EUR 651.89 million, primarily reflecting EUR 679.59 million from reversals of prior-period write-downs.
- Cash and cash equivalents increased to EUR 964.36 million from EUR 616.04 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BTC surpasses $71,000
Euro Falls as US Dollar gains on inflation concerns, Fed rate hike bets
AMD (AMD.US) Enters the "Trillion-Dollar Quantum Track": Partners with PsiQuantum to Develop Fault-Tolerant, Practical-Scale Quantum Infrastructure and Plans to Invest
AMD announced that it has expanded its partnership with PsiQuantum to jointly design infrastructure capable of supporting the operation of fault-tolerant, practical-scale quantum computers.
While the industry faces turmoil, "Nvidia-backed" Nscale presses ahead for NYSE listing! New IPO prospectus reveals 1,344% surge in revenue but a quarterly net loss of $1.69 billion
Nscale, a "New Cloud" provider backed by Nvidia, submitted its latest filing for an initial public offering (IPO) in the United States on Thursday.
Crypto prices
More
